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Abstract
Retinal guanylyl cyclases (RetGCs) in vertebrate photoreceptors are regulated by the gua-
nylyl cyclase activator proteins (GCAP1 and GCAP2). Here, we report EPR double elec-
tron-electron resonance (DEER) studies on the most ubiquitous GCAP isoform, GCAP1
and site-directed mutagenesis analysis to determine an atomic resolution structural model
of a GCAP1 dimer. Nitroxide spin-label probes were introduced at individual GCAP1 resi-
dues: T29C, E57C, E133C, and E154C. The intermolecular distance of each spin-label
probe (measured by DEER) defined restraints for calculating the GCAP1 dimeric structure
by molecular docking. The DEER-derived structural model of the GCAP1 dimer was similar
within the experimental error for both the Mg2+-bound activator and Ca2+-bound inhibitor
states (RMSD < 2.0 Å). The GCAP1 dimer possesses intermolecular hydrophobic contacts
involving the side chain atoms of H19, Y22, F73 and V77. The structural model of the dimer
was validated by GCAP1 mutations (H19R, Y22D, F73E, and V77E) at the dimer interface
that each abolished protein dimerization. Previous studies have shown that each of these
mutants either diminished or completely suppressed the ability of GCAP1 to activate the
cyclase. These results suggest that GCAP1 dimerization may affect compartmentalization
of GCAP1 in the photoreceptors and/or affect regulation of the cyclase activity.
Introduction
Retinal guanylyl cyclase activator proteins (GCAP1[1] and GCAP2[2]) are the two most ubiq-
uitous among the animal species EF-hand calcium sensor proteins in vertebrate photoreceptor
rod and cone cells[3]. Both GCAP1 and GCAP2 control Ca2+-sensitive activation of retinal
guanylyl cyclases (RetGCs[4–7]) that is crucial for promoting the recovery phase of the photo-
response [6, 8]. Visual excitation causes hydrolysis of cGMP in photoreceptor cells and pro-
motes closure of cGMP-gated channels[9, 10], which lowers the cytosolic Ca2+ concentration
from ~250–500 nM in the dark down to<50 nM in the light[11, 12]. The light-induced
decrease in Ca2+ causes the formation of Ca2+-free/Mg2+-bound GCAPs to activate RetGC
[13], whereas Ca2+-bound GCAPs inhibit RetGC at high Ca2+ levels maintained in the dark
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Lim S, Roseman G, Peshenko I,
Manchala G, Cudia D, Dizhoor AM, et al. (2018)
Retinal guanylyl cyclase activating protein 1 forms
a functional dimer. PLoS ONE 13(3): e0193947.
https://doi.org/10.1371/journal.pone.0193947
Editor: Eugene A. Permyakov, Russian Academy of
Medical Sciences, RUSSIAN FEDERATION
Received: January 16, 2018
Accepted: February 21, 2018
Published: March 7, 2018
Copyright: © 2018 Lim et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in
any medium, provided the original author and
source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This work was supported by National
Institutes of Health, National Eye Institute, award
number EY012347 (JBA); National Institutes of
Health, National Eye Institute, award number
EY011522 (AMD). The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
[14–16]. Mutations that impair Ca2+ binding to GCAP1 cause constitutive activation of RetGC
[17–25] and these GCAP mutations are genetically linked to retinal degenerative diseases,
dominant cone- and cone-rod degenerations [26]. Animal models expressing constitutively
active GCAP1 mutants linked to the diseases demonstrate that the congenital blindness is trig-
gered by abnormally high cGMP and intracellular Ca2+ concentrations resulting from the
deregulation of RetGC by GCAPs[11, 27].
The structure of GCAP1 contains 4 EF-hands (EF1, EF2, EF3 and EF4) and N-terminal myris-
toylation (Fig 1A). The atomic-level structures of GCAP1 indicate relatively small Ca2+-induced
changes in tertiary structure (Fig 1B and 1C). The crystal structure of Ca2+-saturated GCAP1
(cyan in Fig 1B and 1C) and the NMR structure of Ca2+-free/Mg2+-bound GCAP1 (magenta in
Fig 1C) have an overall RMSD< 1.8Å. In addition to Ca2+ binding, GCAPs undergo dimerization
[28–30] that may play a role in regulating RetGC, which also forms a dimer [31, 32]. Ca2+-sensitive
protein dimerization was reported for recoverin[33], neurocalcin[34] and GCAP2[30, 35] that
are structurally quite similar to GCAP1. We hypothesize that quaternary structural changes in a
GCAP1 dimer may allosterically regulate RetGC activity and thus amplify the small Ca
2+
-induced
changes in tertiary structure of GCAP1 akin to the allosteric regulation of O2 binding to hemoglo-
bin[36].
In the current study, we performed EPR DEER analysis to calculate an atomic level struc-
tural model of the GCAP1 dimer. Nitroxide spin-label probes were introduced at four different
sites in GCAP1 (T29C, E57C, E133C and E154C, see Fig 1B) and intermolecular distances
from each site in the GCAP1 dimer were measured by DEER. The DEER distance restraints
define a GCAP1 dimer structure that contains key hydrophobic residues (H19, Y22, F73, V77
and W94) at the dimer interface. Site-directed mutagenesis analysis reveals that key amino
acids mutated at the dimer interface (H19R, Y22D, F73E, V77E, and W94A) each weaken pro-
tein dimerization and drastically reduce cyclase activation. We propose that GCAP1 dimeriza-
tion may facilitate its binding to dimeric RetGC in a 2:2 complex, and cyclase activation by
GCAP1 may involve allosteric conformational changes in quaternary structure analogous to
the R to T transition in hemoglobin[36].
Materials and methods
Expression and purification of GCAP1
Recombinant bovine myristoylated GCAP1 was used throughout this study and bacterial
expression of myristoylated GCAP1 was accomplished by co-expressing the GCAP1 D6S
mutant and yeast N-myristoyl CoA transferase (NMT) in E. coli strain, BL21(DE3) as
described previously[29]. Purification of GCAP1 was achieved using previously described
methods [28, 37]. Typically, 10 mg of final purified GCAP1 protein was obtained from 1 liter
of cell culture. The final protein sample was more than 95% pure as judged by SDS-PAGE.
GCAP1 mutagenesis
Mutations in cDNA coding for a D6S bovine GCAP1 were introduced using a ‘splicing by
overlap extension technique’[38] as previously described in detail[39]. To produce Cys-less
mutant of GCAP1 (GCAP1CL), all original Cys residues in GCAP1 were substituted by Thr.
Subsequent introduction of single and double Cys residues was done using the GCAP1CL
cDNA as a template. The resultant cDNA constructs were ligated into the NcoI/BamHI sites of
pET11d vector (Novogen/Calbiochem) for subsequent expression in E. coli as described
above.
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Analytical size exclusion chromatography (SEC)
The molar mass of GCAP1 and mutants in the presence of saturating Mg2+ (2 mM) or Ca2+ (2
mM) was determined using analytical SEC (Superdex 200 HR 10/30 column, GE Healthcare).
The calibration procedure was described by [40]. A sample volume of 100 μL (200 μM protein
concentration) was applied to the column equilibrated with standard sample buffer (10 mM
Tris (pH 7.4), 100 mM NaCl, and 1 mM dithiothreitol) at 4˚C with a flow rate of 0.5 ml/min.
NMR spectroscopy
Samples of GCAP1 and mutants for NMR experiments consisted of 15N-labeled myristoylated
and Mg2+-bound GCAP1 (0.5 mM) concentrated in 10 mM Tris (pH 7.4) buffer containing 2
mM MgCl2, 1 mM DTT-d10 and 90%:10% H2O:D2O. All NMR experiments were performed
at 37˚C on a Bruker 800 MHz Avance III spectrometer equipped with a triple resonance cryo-
genic TCI probe and pulsed field gradients. 2D 15N-1H HSQC spectra were recorded with
2048 (1H) x 256 (15N) data points.
Fig 1. Primary and tertiary structure of GCAP1. (A) Amino acid sequence of bovine GCAP1, (B) crystal structure of GCAP1 in the Ca2+-saturated state (cyan, PDB
code: 2R2I), and (C) overlay of GCAP1 crystal structure (cyan) with NMR Structure of GCAP1 in the Ca2+-free/Mg2+-bound state (red, PDB code: 2NA0). EF-hand
motifs in the primary sequence are shaded in color (EF1 green, EF2 red, EF3 cyan and EF4 yellow). GCAP1 residues substituted with cysteine (T29C, E57C, K67C,
E133C, E154C) that are attached to a nitroxide spin-label in DEER studies are highlighted in bold and red. Key residues at the dimer interface are highlighted bold and
black. N-terminal myristoyl group is colored magenta. Bound Ca2+ and Mg2+ are colored orange and green, respectively.
https://doi.org/10.1371/journal.pone.0193947.g001
Structure of GCAP1 dimer
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Spin labeling and DEER sample preparation
Protein samples were dialyzed against 4 L dialysis buffer in 20 mM Tris (pH 7.4) with 100 μM
TCEP overnight at 4˚C and diluted to 20 μM. The spin-label (1 oxyl 2,2,5,5-tetramethyl-
Δ3-pyrroline-3-methyl) methanethiosulfonate spin-label (MTSSL, Toronto Research Chemi-
cals Inc., Toronto, Canada) was dissolved in dimethylsulfoxide (DMSO) to a concentration of
40 mM. Excess MTSSL was added to protein at a 50:1 molar ratio and then reacted on ice for
30 min. Unreacted spin-labels were removed by dialyzing overnight at 4˚C against 4 L dialysis
buffer containing 20 mM Tris (pH 7.4) and repeated twice. The protein was concentrated to
final concentration of ~300 μM by ultrafiltration using Amicon spin concentrator. The final
protein sample for DEER experiments was exchanged three times with 10 mM Tris-d11 (pH
7.4), 2 mM MgCl2 and 99.9% D2O. Before sample freezing, 25% glycerol-d8 was added to the
protein as a cryo-protectant.
EPR-DEER measurements
4-pulse DEER data was collected on a Bruker ELEXSYS E580 X-band spectrometer equipped
with an MD-5 dielectric resonator and a second frequency DEER module (Bruker). The pump
pulse was fixed to the center peak in the field swept nitroxide spectrum and the probe fre-
quency was chosen 65–75 MHz away from this frequency. π/2 and π pulses were 16 and 32 ns,
respectively. The delay between the first and second probe pulses was 400 ns and dipolar evo-
lution data was collected out to 2.5–4.0 μs. Experiments were run at 50 or 80 K, depending on
the sample, and were signal averaged for 8–24 hr. The raw data was background corrected and
analyzed by Tikhonov regularization using the LongDistances program processed with Lab-
ViewTM. CW-EPR spectra of the DEER samples were recorded at 123 K with a Bruker EMX
EPR spectrometer operating at the X-band frequency (~9.4 GHz) using an ER 4122SHQE res-
onator (Bruker).
Retinal guanylyl cyclase assays
The human RetGC1 cDNA was expressed in HEK293 cells from a modified pRCCMV vector
(Invitrogen) using calcium phosphate precipitation for the transfection, and the membrane
fraction containing expressed RetGC1 was isolated and assayed for activity as previously
described in detail[13]. Briefly, the assay mixture (25 μL) incubated at 30˚C contained 30 mM
MOPS–KOH (pH 7.2), 60 mM KCl, 4 mM NaCl, 1mM DTT, 2 mM Ca2+/EGTA buffer, 1 mM
free Mg2+, 0.3 mM ATP, 4 mM cGMP, 1 mM GTP, and 1 μCi of [α-32P]GTP. The resultant
[32P]cGMP product was separated by TLC using fluorescently-backed polyethyleneimine cel-
lulose plates (Merck) developed in 0.2 M LiCl, eluted with 2 M LiCl and the radioactivity was
counted using ScintiSafe liquid scintillation cocktail containing 20% ethanol.
Molecular docking calculation
The web-based docking program HADDOCK[41] was used to generate a structural model of
the GCAP1 dimer using the NMR structure of bovine GCAP1 V77E mutant (PDB ID: 2NA0) as
a template structure. Intermolecular distance restraints derived from DEER measurements on
GCAP1 mutants (GCAP1CL(E57C), GCAP1CL(E133C), and GCAP1CL(E154C)) served as input
for the docking calculation. Since the DEER intermolecular distance distribution for E57C
showed two maxima at 26 and 50 Å, two separate calculations were performed using the follow-
ing intermolecular distance restraints. For the first calculation (symmetric dimer in Table 1), the
following intermolecular distance restraints were used: 50 Å (E57C), 50 Å (E133C), and 28 Å
(E154C). A second calculation (asymmetric dimer in Table 1) used 26 Å (E57C), 50 Å (E133C),
Structure of GCAP1 dimer
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and 28 Å (E154C). An error margin of ±5Å was applied to each restraint. Table 1 lists the dis-
tance restraints and HADDOCK parameters used in each calculation.
The docking calculation within HADDOCK used rigid body energy minimization that gen-
erated 5000 structures. The best 200 structures were subjected to a semi-flexible simulated
annealing step. In the final step, the 200 structures obtained from the simulated annealing step
were refined in explicit waters. The 200 water refined structures were classified into 12 clusters
(symmetric dimer) and 3 clusters (asymmetric dimer) as shown in S1 Fig. The cluster having
the lowest interface RMSD (i-RMSD) was chosen for analysis and the statistics of this cluster
are summarized in Table 1.
Results
Intermolecular distances of a GCAP1 dimer by EPR-DEER
Previous studies demonstrated that GCAP1 forms a dimer in solution[28, 29]. In this study,
we analyzed EPR-DEER measurements to calculate a structural model of the GCAP1 dimer.
DEER experiments were performed on GCAP1 and were analyzed to measure intermolecular
distances between individual nitroxide spin-labels covalently attached to particular Cys resi-
dues on the protein surface (T29C, E57C, E133C, and E154C). Wild type GCAP1 contains
four native Cys residues (C18, C29, C106 and C125) that in principle could be spin-labeled.
Unfortunately, the attachment of a spin-label at each native Cys interfered with GCAP1 dimer-
ization or caused protein aggregation. Therefore, in subsequent mapping of the intermolecular
intractions by DEER, we eliminated the native Cys residues by replacing them with Thr and
then introduced a single Cys in various positions. Each native Cys residue was mutated to Thr
to produce a Cys-less mutant, GCAP1CL. Since Cys29, unlike all other Cys residues in GCAP1,
is a part of the RetGC-binding interface[39], the original C29T substitution in the GCAP1CL
reduced affinity of the Cys-less protein for the cyclase compared to the wild type (EC50 of 14
vs< 2 μM, respectively), but the GCAP1CL was still able to strongly activate the cyclase at
higher concentrations in the absence of Ca2+ (Fig 2). Single Cys mutants of GCAP1 were gen-
erated by introducing a Cys residue in place of a particular exposed residue in the Cys-less
GCAP1 (GCAP1CL(T29C), GCAP1CL(E57C), GCAP1CL(E133C), and GCAP1CL(E154C)).
Each of the single Cys mutants were then individually labeled with a nitroxide spin label, and
the intermolecular distance between the attached spin label was measured for each mutant
using DEER. The GCAP1 Cys-less mutant and each of the single-Cys mutants (GCAP1CL
(T29C), GCAP1CL(E57C), GCAP1CL(E133C), and GCAP1CL(E154C)) were all shown to be
Table 1. Molecular docking statistics for GCAP1.
Symmetric Dimer Asymmetric Dimer
DEER distance restraint E57C Sγ: 50 ± 5 Å E57C Sγ: 26 ± 5 Å
DEER distance restraint E133C Sγ: 50 ± Å E133C Sγ: 50 ± Å
DEER distance restraint E154C Sγ: 28 ± Å E154C Sγ: 28 ± Å
Calculated distance E57C Sγ: 46 Å E57C Sγ: 36 Å
Calculated distance E133C Sγ: 55 Å E133C Sγ: 45 Å
Calculated distance E154C Sγ: 35 Å E154C Sγ: 29 Å
HADDOCK Energy -181.3 ± 5.8 -133.8 ± 5.5
RMSD (Å)a 0.6 ± 0.3 0.7 ± 0.4
Cluster size 30 47
aroot mean squared deviation of backbone heavy atoms.
https://doi.org/10.1371/journal.pone.0193947.t001
Structure of GCAP1 dimer
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functional and capable of activating RetGC in a Ca2+-sensitive manner (Fig 2); however,
RetGC activation by these mutants required higher GCAP1 concentrations (EC50 = 5–14 μM)
compared to wild type (EC50 < 2 μM), except for the GCAP1CL(T29C), which activated
RetGC1 in a manner indistinguishable from the wild type, because the original Cys29 in the
cyclase-binding interface became restored in that mutant.
Representative DEER data for each nitroxide-labeled GCAP1 single Cys mutant (GCAP1-
CL(E57C), GCAP1CL(E133C) and GCAP1CL(E154C)) are shown in Fig 3. The DEER data for
GCAP1CL(E57C) (Fig 3A) was best modeled by a bimodal distance distribution (Fig 3B) that
has two most probable intermolecular distances at 26 ±5 Å and 50 ±5 Å. The bimodal distance
distribution suggests there may be two populations of structurally distinct GCAP1 dimers. The
DEER data for GCAP1CL(E133C) (Fig 3C) was accurately modeled by a single distance distri-
bution (Fig 3D) with a most probable intermolecular distance of 50 ±5 Å. The DEER data for
GCAP1CL(E154C) (Fig 3E) was fit to a single distance distribution (Fig 3F) with a most proba-
ble intermolecular distance of 28 ±3 Å. The measured DEER intermolecular distances are
listed in Table 1.
The intermolecular distance for GCAP1CL(T29C) could not be accurately measured by DEER,
because of apparent strong dipolar coupling of the nitroxide spin label attached at T29C. Evi-
dence of strong dipolar coupling of the nitroxide at this site is evident in the CW-EPR spectrum
of GCAP1CL(T29C) (Fig 4A) that exhibited a broad shoulder and multiplet lineshape. By con-
trast, the CW-EPR spectra of GCAP1CL(E57C) (Fig 4B) and GCAP1CL(E133C) (Fig 4C) exhib-
ited well-resolved and sharp resonances, consistent with a solvent exposed nitroxide with an
intermolecular distance of greater than 20 Å [42]. The strong dipolar coupling of the nitroxide at
T29C would imply a spin-label intermolecular distance of less than 9Å. However, such a short
intermolecular distance for T29C is inconsistent with the intermolecular DEER distances mea-
sured above for GCAP1CL(E57C), GCAP1CL(E133C), and GCAP1CL(E154C) (Fig 3). We hypoth-
esized that the 9Å intermolecular distance for T29C might be the result of higher order protein
multimers (eg a dimer of dimers) that is not seen in the wild type protein. Indeed, the HSQC
NMR spectrum of GCAP1CL(T29C) containing an attached spin-label (with the N-O group
reduced [43]) has considerably broader NMR peaks compared to wild type GCAP1 (Fig 4D).
Also, NMR pulsed-field gradient diffusion studies [44] on spin-labeled GCAP1CL(T29C) deter-
mined a translational diffusion coefficient (D = 2.0 x 10−10 m2/s) consistent with a molar mass of
~100 kDa, which corresponds to a protein tetramer for the spin-labeled GCAP1CL(T29C) in con-
trast to the dimeric wild type protein [29]. These results suggest that the strong dipolar coupling
observed for the spin-labeled GCAP1CL(T29C) may be the result of protein tetramerization and/
or aggregation that is not seen in the wild type protein dimer. Therefore, the strong dipolar cou-
pling of the nitroxide attached at T29C is possibly an artifact of protein aggregation and will not
be included in the dimeric structural model below.
Structural model of a GCAP1 dimer
The intermolecular distances for each of the spin-labeled GCAP1 mutants measured by DEER
(Fig 3) were used as distance restraints within HADDOCK[45] to calculate the structure of the
GCAP1 dimer as described in Methods. The bimodal DEER distance distribution for GCAP1CL
Fig 2. Single-Cys GCAP1 mutants retain the ability to regulate RetGC. Membranes from HEK 293 cells expressing guanylyl cyclase RetGC1 were
reconstituted with the purified recombinant myristoylated GCAP1 and assayed as described under Materials and Methods. (A) RetGC1 activity after
reconstitution with 10 μM wild type, Cys-less GCAP1CL and single-Cys mutants measured in the presence of either EGTA (<10 nM free Ca2+) or 50 μM
free Ca2+; mean average ± SD from 3 measurements. (B) Dose-dependence of the cyclase activation in the presence of EGTA by wild type GCAP1 (), a
Cys-less mutant GCAP1CL(●) or mutants containing a single Cys, GCAP1CL(T29C) (▲), GCAP1CL(E57C) (), GCAP1CL(E133C(◆), and
GCAP1CL(E154C) (4); mean average ± SD from 3 independent experiments.
https://doi.org/10.1371/journal.pone.0193947.g002
Structure of GCAP1 dimer
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(E57C) (Fig 3B) suggests that the two distance components may represent two different GCAP1
dimer structures. Therefore, the distance restraints (intermolecular distances between spin labels
attached at E57C, E133C and E154C in Table 1) were analyzed to calculate two separate structural
models that represent each distance component for GCAP1CL(E57C). One of the models is a sym-
metric dimer that has a E57C intermolecular distance matching the long distance component at
~50Å (Fig 5A). The other model is an asymmetric dimer that has the E57C intermolecular dis-
tance matching the shorter distance component at 26 Å (Fig 5B).
The GCAP1 symmetric dimer (Fig 5A) is stabilized structurally by intermolecular hydro-
phobic contacts at the dimer interface. The most central contacts are formed between H19,
Y22 and V77 (Fig 5C). The V77 side-chain methyl groups make intermolecular contact with
each other at the dimer interface (Fig 5C). The intermolecular contact involving V77 is partic-
ularly important, which explains why the V77E mutation abolished GCAP1 dimerization[29].
The aromatic side-chains of H19 and Y22 also make intermolecular contacts with each other
at the dimer interface (Fig 5C). The symmetric dimer is further stabilized by intermolecular
hydrophobic contacts between aromatic side chains of F73 and W94 (Fig 5D). The symmetric
GCAP1 dimer (Fig 5A) is structurally quite similar to the dimeric structural model reported
recently for GCAP5 [40].
The GCAP1 asymmetric dimer (Fig 5B) has both hydrophobic and polar residues at the
dimer interface. The hydrophobic residues observed at the dimer interface in the symmet-
ric dimer (H19, Y22, V77 and W94) are also located at the dimer interface in the asym-
metric dimer (Fig 5E). Surprisingly, the hydrophobic residues (H19 and V77) both make
intermolecular contacts with polar residues at the dimer interface. The side chain methyl
groups of V77 form intermolecular contacts with the negatively charged side chain of
D68, and the aromatic imidazole side chain of H19 forms intermolecular contacts with
the side chain atoms of Q58 (Fig 5E). The asymmetric dimer is also stabilized by intermo-
lecular hydrophobic contacts between the aromatic ring of Y22 and methyl groups of L36
(Fig 5E).
To discriminate the two dimeric GCAP1 structures (symmetric vs asymmetric), we
constructed a mutant (F73E) that is predicted to disrupt key intermolecular hydrophobic
contacts between F73, V77 and W94 in the symmetric dimer (Fig 5D), whereas the F73E
mutation is predicted to have less of an effect on the asymmetric dimer. The 1H-15N HSQC
NMR spectrum of 15N-labeled F73E mutant (red peaks in Fig 6A) exhibited a greater num-
ber of much sharper NMR peaks compared to those of wildtype GCAP1 (black peaks in Fig
6A), which were broader and less sensitively detected. The sharper and narrower NMR
peaks observed for the F73E mutant suggest that the mutant protein is a monomer in con-
trast to the dimeric wild type protein. In addition, the F73E mutation was shown previously
to dramatically decrease its ability to activate RetGC[46]. The effect of the F73E mutation
on both protein dimerization and cyclase activation suggests that the symmetric dimer (Fig
5A) is biologically relevant.
Fig 3. EPR-DEER intermolecular distances for GCAP1. Representative EPR-DEER data of GCAP1CL(E57C) (A), GCAP1CL(E133C)
(C), and GCAP1CL(E154C) (E), and corresponding distance distributions of GCAP1CL(E57C) (B), GCAP1CL(E133C) (D), and
GCAP1CL(E154C) (F). GCAP1 samples were in the Ca2+-free/Mg2+-bound state. Similar DEER data were observed for GCAP1 in the
Ca2+-bound state. A nitroxide spin-label (MTSSL) was covalently attached to the sole Cys residue in each mutant. The distance
distributions and average intermolecular distances were calculated on the basis of the DEER data as described in Methods. The
bimodal distance distribution for GCAP1CL(E57C) suggest there are two populations of GCAP1 dimers with distinct structure near
E57C. The DEER intermolecular distances were measured to be 26±3/50±5 Å (GCAP1CL(E57C) in panel B), 50 ±5Å
(GCAP1CL(E133C) in panel D), and 28 ±3Å (GCAP1CL(E154C) in panel F).
https://doi.org/10.1371/journal.pone.0193947.g003
Structure of GCAP1 dimer
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 9 / 17
Mutations at GCAP1 dimer interface abolish dimerization
To validate the structures of the GCAP1 dimer (Fig 5A and 5B), residues at the dimer interface
were each mutated (H19R, Y22D, F73E and V77E). The molecular size of each GCAP1 mutant
in solution was determined by size exclusion chromatography (Fig 6B). The elution time of
Fig 4. Spin-label attached to GCAP1CL(T29C) has restricted motion. CW-EPR spectra of GCAP1CL(T29C) (A), GCAP1CL(E57C) (B) and GCAP1CL(E133C) (C) at
123 K. (D) NMR 1H-15N HSQC spectra of 15N-labeled GCAP1CL(T29C) containing an attached spin-label with the N-O group reduced (red) and wildtype GCAP1
(black). Spectral parameters are described in Methods.
https://doi.org/10.1371/journal.pone.0193947.g004
Structure of GCAP1 dimer
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wild type GCAP1 corresponded to a molar mass of 42 kDa, indicating that wild type GCAP1 is
a dimer in solution at protein concentrations above 100 μM[29]. The addition of saturating
Ca2+ and/or Mg2+ had no detectable effect on the elution time of wild type GCAP1 or any of
the mutants. The elution times of each mutant (H19R, Y22D, F73E and V77E) corresponded
to a molar mass of 24 kDa, demonstrating that each mutant is a monomer in solution. There-
fore, mutating each of the key residues at the dimer interface (H19R, Y22D, F73E and V77E)
significantly weakened the dimerization association constant, which validates the structural
models of the GCAP1 dimer (Fig 6A and 6B).
Discussion
We present EPR-DEER (Figs 3 and 4) and mutagenesis functional analysis (Figs 2 and 6) to
demonstrate that GCAP1 forms a dimer (Fig 5), which we suggest can be functionally impor-
tant for cyclase activation. The structure of the GCAP1 dimer is summarized in Fig 5. A cluster
Fig 5. Structural model of GCAP1 dimer. Ribbon diagram of main chain structures of the GCAP1 symmetric dimer (A) and asymmetric dimer (B) that are both
consistent with DEER intermolecular distances for spin-label attached to E57C, E133C and E154C. Exposed residues mutated to Cys for DEER studies (E57, E133 and
E154) are colored red in panels A and B. Myristoyl group is highlighted magenta. (C) Close-up view of the symmetric dimer showing hydrophobic residues (side-chains
of H19, Y22, and V77 colored yellow) at the dimer interface. (D) Close-up view of the symmetric dimer showing intermolecular hydrophobic contacts between Y22,
F73, V77 and W94. (E) Close-up view of the asymmetric dimer showing hydrophobic residues (H19, Y22, and V77 colored yellow) at the dimer interface.
https://doi.org/10.1371/journal.pone.0193947.g005
Structure of GCAP1 dimer
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of hydrophobic residues (H19, Y22, F73 and V77) form important intermolecular contacts at
the dimer interface that greatly stabilize the dimer (Fig 5C and 5D). Site-directed mutagenesis
of the residues at the dimer interface (H19R, Y22D, F73E, and V77E) each abolished dimeriza-
tion (Fig 6) and prevented activation of RetGC[46]. We reason that dimeric GCAP1 may inter-
act with the RetGC dimer to form a 2:2 complex, and quaternary structural changes in the
dimer may play a role in regulating the cyclase activity during visual phototransduction.
Previous mutagenesis studies have mapped a cluster of residues on the surface of GCAP1
that are critical for cyclase activation [39, 47, 48]. Many of these GCAP1 residues that are
essential for activating the cyclase (H19, Y22, F73, and V77) are also located at the GCAP1
dimer interface (Fig 5C and 5D). One possible interpretation is that dimerization of GCAP1
(Fig 5) may be a prerequisite for it to bind and activate the cyclase. Indeed, the mutations in
this study that each abolished dimerization (H19R, Y22D, F73E and V77E) also prevented acti-
vation of RetGC [39]. This suggests that a pre-formed GCAP1 dimer may facilitate its binding
to the dimeric cyclase and GCAP1 dimerization could help stabilize a high affinity 2:2 target
complex.
An alternative possibility is that the GCAP1 dimer that forms in solution (and in the
absence of RetGC) may dissociate upon binding to membrane-bound RetGC (Fig 7). Muta-
tions that disrupt GCAP1 dimerization also either drastically (H19R) or completely (Y22D,
F73E, and V77E) suppress the ability of GCAP1 to activate its primary target enzyme, RetGC1
[39]. The last three mutations also prevent the binding of GCAP1 to RetGC1, which was
probed by fluorescently labeled RetGC1 and GCAP1 co-expressed in the same cells[39].
Hence, the dimer interface partially overlaps with the cyclase binding site[39], with several res-
idues (His19, Tyr22, Phe73, Val77 and Trp94) being part of both interfaces (Fig 7A). In this sce-
nario, the residues at the GCAP1 dimerization site may prefer to interact more strongly with
RetGC (rather than itself) once GCAP1 is in close proximity to the target enzyme. The binding
of RetGC to GCAP1 in this context would be expected to disrupt GCAP1 dimerization in
favor of binding with the cyclase (Fig 7B). The exact concentration of GCAP1 in the inner seg-
ment, and especially its local concentration at the points of assembly with the cyclase is impos-
sible to estimate at present, but we hypothesize that dimerization of GCAP1 in the absence of
the target enzyme could explain the inability of GCAP1 to efficiently accumulate in the rod
outer segments lacking RetGC1[49]. According to this hypothesis, only GCAP1 associated
with the RetGC would be carried into the outer segment by a vesicle transport mechanism that
delivers the membrane-bound cyclase to the photoreceptor disks. By contrast, the passive dif-
fusion of cytosolic dimeric GCAP1 (that is not bound to the cyclase) into the outer segment
may be restricted by the size of the GCAP1 dimer (Fig 7B). To distinguish whether GCAP1
dimerization facilitates or opposes RetGC binding, future EPR-DEER studies are needed to
probe whether or not the structure of the GCAP1 dimer (Fig 5) will remain intact when
GCAP1 is bound to RetGC. Additional in vivo studies of GCAP1 and RetGC1 co-transport are
also needed to elucidate compartmentalization of RetGC vs. dimeric or the monomeric of
GCAP1 in the photoreceptor cell.
Fig 6. Mutations at the GCAP1 dimer interface abolish dimerization. (A) 1H-15N HSQC NMR spectra of 15N-labeled wild type GCAP1 (black)
and GCAP1 mutant, F73E (red) in the Ca2+-bound state. The NMR peaks of the F73E mutant are sharper and more sensitively detected than the
corresponding peaks from wild type GCAP1. The conditions for the NMR experiments were the same as described previously[29]. (B) SEC analysis
of GCAP1 mutants: H19R (red), Y22A (blue), F73E (green), and wild type (black). The elution time of wildtype GCAP1 in the Mg2+-bound state
corresponded to a molar mass of 42 ±4 kDa (relative to protein standards), and the molar mass of each mutant was calculated to be 24 ±2 kDa. The
addition of saturating Ca2+ or Mg2+ had no effect on the elution times. The SEC experimental conditions are described in Methods.
https://doi.org/10.1371/journal.pone.0193947.g006
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Supporting information
S1 Fig. Cluster analysis of HADDOCK docking calculation.
(PDF)
Author Contributions
Conceptualization: Alexander M. Dizhoor, James B. Ames.
Data curation: Sunghyuk Lim, Graham Roseman, Igor Peshenko, Grace Manchala, Diana
Cudia.
Formal analysis: Sunghyuk Lim, Graham Roseman, Igor Peshenko, Diana Cudia.
Fig 7. A hypothetical function of GCAP1 dimerization in photoreceptor cells. (A) The RetGC-binding site (red) and dimerization interface (yellow) in GCAP1
overlap. The residues essential for regulation of the cyclase[39] are highlighted in red and those that are required for dimerization of GCAP1 in solution are highlighted
in yellow. (B) GCAP1 (in excess of RetGC) in the inner segment forms a dimer via its dimerization interface, which prevents GCAP1 diffusion into the outer segment.
The binding of RetGC to GCAP1 disrupts the GCAP1 dimer, which allows the RetGC/GCAP1 complex to incorporate in transport vesicles that are then transported to
the outer segment. In the outer segment, the RetGC/GCAP1 complex is translocated into disk membranes, where it forms a 2:2 complex.
https://doi.org/10.1371/journal.pone.0193947.g007
Structure of GCAP1 dimer
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 14 / 17
Funding acquisition: Alexander M. Dizhoor, Glenn Millhauser.
Investigation: Sunghyuk Lim, Glenn Millhauser, James B. Ames.
Methodology: Sunghyuk Lim, Graham Roseman, Igor Peshenko, Grace Manchala, Diana
Cudia.
Project administration: Alexander M. Dizhoor, Glenn Millhauser, James B. Ames.
Supervision: Alexander M. Dizhoor, Glenn Millhauser, James B. Ames.
Writing – original draft: James B. Ames.
Writing – review & editing: Sunghyuk Lim, Graham Roseman, Igor Peshenko, Alexander M.
Dizhoor, Glenn Millhauser, James B. Ames.
References
1. Palczewski K, Subbaraya I, Gorczyca WA, Helekar BS, Ruiz CC, Ohguro H, et al. Molecular cloning
and characterization of retinal photoreceptor guanylyl cyclase-activating protein. Neuron. 1994; 13
(2):395–404. PMID: 7520254
2. Dizhoor AM, Olshevskaya EV, Henzel WJ, Wong SC, Stults JT, Ankoudinova I, et al. Cloning, sequenc-
ing and expression of a 24-kDa Ca2+-binding protein activating photoreceptor guanylyl cyclase. J Biol
Chem. 1995; 270:25200–6. PMID: 7559656
3. Palczewski K, Polans AS, Baehr W, Ames JB. Ca(2+)-binding proteins in the retina: structure, function,
and the etiology of human visual diseases. Bioessays. 2000; 22:337–50. https://doi.org/10.1002/(SICI)
1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z PMID: 10723031
4. Dizhoor AM, Lowe DG, Olsevskaya EV, Laura RP, Hurley JB. The human photoreceptor membrane
guanylyl cyclase, RetGC, is present in outer segments and is regulated by calcium and a soluble activa-
tor. Neuron. 1994; 12(6):1345–52. PMID: 7912093
5. Lowe DG, Dizhoor AM, Liu K, Gu Q, Spencer M, Laura R, et al. Cloning and expression of a second
photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2. Proc Natl Acad Sci USA.
1995; 6(12):5535–9.
6. Koch KW, Stryer L. Highly cooperative feedback control of retinal rod guanylate cyclase by calcium
ions. Nature. 1988; 334(6177):64–6. https://doi.org/10.1038/334064a0 PMID: 2455233
7. Pannbacker R. Control of guanylate cyclase activity in the rod outer segment. Science. 1973; 182
(4117):1138–40. PMID: 4148001
8. Koch KW, Duda T, Sharma RK. Photoreceptor specific guanylate cyclases in vertebrate phototransduc-
tion. Mol Cell Biochem. 2002; 230(1):97–106.
9. Baylor D. How photons start vision. Proc Natl Acad Sci USA. 1996; 93:560–5. PMID: 8570595
10. Koch KW, Dell’Orco D. Protein and Signaling Networks in Vertebrate Photoreceptor Cells. Frontiers in
molecular neuroscience. 2015; 8:67. https://doi.org/10.3389/fnmol.2015.00067 PMID: 26635520;
PubMed Central PMCID: PMC4646965.
11. Olshevskaya EV, Calvert PD, Woodruff ML, Peshenko IV, Savchenko AB, Makino CL, et al. The Y99C
mutation in guanylyl cyclase-activating protein 1 increases intracellular Ca2+ and causes photoreceptor
degeneration in transgenic mice. J Neurosci. 2004; 24(27):6078–85. https://doi.org/10.1523/
JNEUROSCI.0963-04.2004 PMID: 15240799
12. Woodruff ML, Sampath AP, Mathews HR, Krasnoperova NV, Lem J, Fain GL. Measurement of cyto-
plasmic calcium concentration in the rods of wild-type and transducin knock-out mice. J Physiol. 2002;
542(3):843–54.
13. Peshenko IV, Dizhoor AM. Activation and inhibition of photoreceptor guanylyl cyclase by guanylyl
cyclase activating protein 1 (GCAP-1): the functional role of Mg2+/Ca2+ exchange in EF-hand
domains. J Biol Chem. 2007; 282(30):21645–52. https://doi.org/10.1074/jbc.M702368200 PMID:
17545152
14. Dizhoor AM, Hurley JB. Inactivation of EF-hands makes GCAP-2 (p24) a constitutive activator of photo-
receptor guanylyl cyclase by preventing a Ca2+-induced "activator-to-inhibitor" transition. J Biol Chem.
1996; 271(32):19346–50. PMID: 8702620
15. Krylov DM, Niemi GA, Dizhoor AM, Hurley JB. Mapping sites in guanylyl cyclase activating protein-1
required for regulation of photoreceptor membrane guanylyl cyclases. J Biol Chem. 1999; 274
(16):10833–9. PMID: 10196159
Structure of GCAP1 dimer
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 15 / 17
16. Koch KW, Dell’orco D. A calcium-relay mechanism in vertebrate phototransduction. ACS chemical neu-
roscience. 2013; 4(6):909–17. https://doi.org/10.1021/cn400027z PMID: 23472635; PubMed Central
PMCID: PMC3689192.
17. Dizhoor AM, Boikov SG, Olshevskaya EV. Constitutive activation of photoreceptor guanylate cyclase
by Y99C mutant of GCAP-1. Possible role in causing human autosomal dominant cone degeneration. J
Biol Chem. 1998; 273(28):17311–4. PMID: 9651312
18. Payne AM, Downes SM, Bessant DA, Taylor R, Holder GE, Warren MJ, et al. A mutation in guanylate
cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new
locus on chromosome 6p21.1. Hum Mol Genetics. 1998; 7:273–7.
19. Sokal I, Li N, Surgucheva I, Warren MJ, Payne AM, Bhattacharya SS, et al. GCAP1 (Y99C) mutant is
constitutively active in autosomal dominant cone dystrophy. Mol Cell. 1998; 2(1):129–33. PMID:
9702199
20. Wilkie SE, Li Y, Deery EC, Newbold RJ, Garibaldi D, Bateman JB, et al. Identification and functional
consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant
cone dystrophy. American journal of human genetics. 2001; 69(3):471–80. https://doi.org/10.1086/
323265 PMID: 11484154; PubMed Central PMCID: PMC1235478.
21. Behnen P, Dell’ Orco D, Koch KW. Involvement of the calcium sensor GCAP1 in hereditary cone dystro-
phies. Biol Chem. 2010; 391(6):631–7. https://doi.org/10.1515/BC.2010.063 PMID: 20370318
22. Dell’Orco D, Behnen P, Linse S, Koch KW. Calcium binding, structural stability and guanylate cyclase
activation in GCAP1 variants associated with human cone dystrophy. Cell Mol Life Sci. 2010; 67:973–
84. https://doi.org/10.1007/s00018-009-0243-8 PMID: 20213926
23. Kitiratschky VBD, Behnen P, Kellner U, Heckenlively JR, Zrenner E, Ja¨gle H, et al. Mutations in the
GUCA1A gene involved in hereditary cone dystrophies impair calcium-mediated regulation of guanlyate
cyclase. Hum Mutat. 2009; 30:E782–96. https://doi.org/10.1002/humu.21055 PMID: 19459154
24. Chen X, Sheng X, Zhuang W, Sun X, Liu G, Shi X, et al. GUCA1A mutation causes maculopathy in a
five-generation family with a wide spectrum of severity. Genetics in medicine: official journal of the
American College of Medical Genetics. 2017; 19(8):945–54. https://doi.org/10.1038/gim.2016.217
PMID: 28125083; PubMed Central PMCID: PMC5548935.
25. Vocke F, Weisschuh N, Marino V, Malfatti S, Jacobson SG, Reiff CM, et al. Dysfunction of cGMP signal-
ling in photoreceptors by a macular dystrophy-related mutation in the calcium sensor GCAP1. Human
molecular genetics. 2017; 26(1):133–44. https://doi.org/10.1093/hmg/ddw374 PMID: 28025326.
26. Jiang L, Baehr W. GCAP1 Mutations Associated with Autosomal Dominant Cone Dystrophy. Adv Exp
Med Biol. 2010; 664:273–82. https://doi.org/10.1007/978-1-4419-1399-9_31 PMID: 20238026
27. Woodruff ML, Olshevskaya EV, Savchenko AB, Peshenko IV, Barrett R, Bush RA, et al. Constitutive
excitation by Gly90Asp rhodopsin rescues rods from degeneration caused by elevated production of
cGMP in the dark. The Journal of neuroscience: the official journal of the Society for Neuroscience.
2007; 27(33):8805–15. https://doi.org/10.1523/JNEUROSCI.2751-07.2007 PMID: 17699662; PubMed
Central PMCID: PMC2673730.
28. Lim S, Peshenko IV, Dizhoor AM, Ames JB. Structural insights for activation of retinal guanylate cyclase
by GCAP1. PLoS One. 2013; 8(11):e81822. https://doi.org/10.1371/journal.pone.0081822 PMID:
24236217; PubMed Central PMCID: PMC3827477.
29. Lim S, Peshenko IV, Olshevskaya EV, Dizhoor AM, Ames JB. Structure of Guanylyl Cyclase Activator
Protein 1 (GCAP1) Mutant V77E in a Ca2+-free/Mg2+-bound Activator State. J Biol Chem. 2016; 291
(9):4429–41. https://doi.org/10.1074/jbc.M115.696161 PMID: 26703466; PubMed Central PMCID:
PMC4813471.
30. Olshevskaya EV, Ermilov A.N., and Dizhoor A.M. Dimerization of guanylyl cyclase-activating protein. J
Biol Chem. 1999; 274(36):25583–7. PMID: 10464292
31. Ramamurthy V, Tucker C, Wilkie SE, Daggett V, Hunt DM, Hurley JB. Interactions within the coiled-coil
domain of RetGC-1 guanylyl cyclase are optimized for regulation rather than for high affinity. J Biol
Chem. 2001; 276(28):26218–29. https://doi.org/10.1074/jbc.M010495200 PMID: 11306565
32. Liu Y, Ruoho AE, Rao VD, Hurley JB. Catalytic mechanism of the adenylyl and guanylyl cyclases:
modeling and mutational analysis. Proceedings of the National Academy of Sciences of the United
States of America. 1997; 94(25):13414–9. PMID: 9391039
33. Myers WK, Xu X, Li C, Lagerstedt JO, Budamagunta MS, Voss JC, et al. Double electron-electron reso-
nance probes Ca(2)(+)-induced conformational changes and dimerization of recoverin. Biochemistry.
2013; 52(34):5800–8. https://doi.org/10.1021/bi400538w PMID: 23906368; PubMed Central PMCID:
PMC3784611.
34. Vijay-Kumar S, Kumar VD. Crystal structure of recombinant bovine neurocalcin. Nature Struct Biol.
1999; 6:80–8. https://doi.org/10.1038/4956 PMID: 9886296
Structure of GCAP1 dimer
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 16 / 17
35. Ermilov AN, Olshevskaya EV, Dizhoor AM. Instead of binding calcium, one of the EF-hand structures in
guanylyl cyclase activating protein-2 is required for targeting photoreceptor guanylyl cyclase. J Biol
Chem. 2001; 276(51):48143–8. https://doi.org/10.1074/jbc.M107539200 PMID: 11584009
36. Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model. J Mol Biol.
1965; 12(1):88–118.
37. Lim S, Peshenko IV, Dizhoor AM, Ames JB. Effects of Ca2+, Mg2+, and myristoylation on guanylyl
cyclase activating protein 1 structure and stability. Biochemistry. 2009; 48(5):850–62. https://doi.org/10.
1021/bi801897p PMID: 19143494
38. Horton RM, Pease LR. Directed mutagenesis. Practical approach. McPherson MJ, editor: Oxford Uni-
versity Press; 1991.
39. Peshenko IV, Olshevskaya EV, Lim S, Ames JB, Dizhoor AM. Identification of target binding site in pho-
toreceptor guanylyl cyclase-activating protein 1 (GCAP1). J Biol Chem. 2014; 289(14):10140–54.
https://doi.org/10.1074/jbc.M113.540716 PMID: 24567338; PubMed Central PMCID: PMC3974984.
40. Lim S, Scholten A, Manchala G, Cudia D, Zlomke-Sell SK, Koch KW, et al. Structural Characterization
of Ferrous Ion Binding to Retinal Guanylate Cyclase Activator Protein 5 from Zebrafish Photoreceptors.
Biochemistry. 2017; 56(51):6652–61. https://doi.org/10.1021/acs.biochem.7b01029 PMID: 29172459;
PubMed Central PMCID: PMC5743585.
41. van Zundert GC, Rodrigues JP, Trellet M, Schmitz C, Kastritis PL, Karaca E, et al. The HADDOCK2.2
Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. Journal of molecular biol-
ogy. 2016; 428(4):720–5. https://doi.org/10.1016/j.jmb.2015.09.014 PMID: 26410586.
42. Hustedt EJ, Stein RA, Sethaphong L, Brandon S, Zhou Z, Desensi SC. Dipolar coupling between nitrox-
ide spin labels: the development and application of a tether-in-a-cone model. Biophysical journal. 2006;
90(1):340–56. https://doi.org/10.1529/biophysj.105.068544 PMID: 16214868; PubMed Central PMCID:
PMC1367032.
43. Bolin KA, Hanson P, Wright SJ, Millhauser GL. An NMR Investigation of the Conformational Effect of
Nitroxide Spin Labels on Ala-Rich Helical Peptides. J Magn Reson. 1998; 131(1):248–53.
44. Altieri AS, Hinton DP, Byrd RA. Association of biomolecular systems via pulsed field gradient NMR self-
diffusion measurements. J Am Chem Soc. 1995; 117:7566–7.
45. de Vries SJ, van Dijk M, Bonvin AM. The HADDOCK web server for data-driven biomolecular docking.
Nat Protoc. 2010; 5(5):883–97. https://doi.org/10.1038/nprot.2010.32 PMID: 20431534
46. Peshenko IV, Olshevskaya EV, Dizhoor AM. Functional Study and Mapping Sites for Interaction with
the Target Enzyme in Retinal Degeneration 3 (RD3) Protein. J Biol Chem. 2016; 291(37):19713–23.
https://doi.org/10.1074/jbc.M116.742288 PMID: 27471269; PubMed Central PMCID: PMC5016703.
47. Marino V, Dell’Orco D. Allosteric communication pathways routed by Ca(2+)/Mg(2+) exchange in
GCAP1 selectively switch target regulation modes. Scientific reports. 2016; 6:34277. https://doi.org/10.
1038/srep34277 PMID: 27739433; PubMed Central PMCID: PMC5064319.
48. Schrem A, Lange C, Beyermann M, Koch KW. Identification of a domain in guanylyl cyclase-activating
protein 1 that interacts with a complex of guanylyl cyclase and tubulin in photoreceptors. J Biol Chem.
1999; 274(10):6244–9. PMID: 10037711
49. Olshevskaya EV, Peshenko IV, Savchenko AB, Dizhoor AM. Retinal guanylyl cyclase isozyme 1 is the
preferential in vivo target for constitutively active GCAP1 mutants causing congenital degeneration of
photoreceptors. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2012;
32(21):7208–17. https://doi.org/10.1523/JNEUROSCI.0976-12.2012 PMID: 22623665; PubMed Cen-
tral PMCID: PMC3368705.
Structure of GCAP1 dimer
PLOS ONE | https://doi.org/10.1371/journal.pone.0193947 March 7, 2018 17 / 17
